Author:
Rosario-Berríos Derick N.,Pang Amanda,Liu Leening P.,Maidment Portia S. N.,Kim Johoon,Yoon Seokyoung,Nieves Lenitza M.,Mossburg Katherine,Adezio Andrew,Noel Peter,Lennon Elizabeth M.,Cormode David P.
Abstract
AbstractUlcerative colitis (UC) is a chronic inflammatory bowel disease (IBD). CT imaging with contrast agents is commonly used for visualizing the gastrointestinal (GI) tract in UC patients. CT is a common imaging modality for evaluating IBD, especially in patients with acute abdominal pain presenting to emergency departments. CT’s major limitation lies in its lack of specificity for imaging UC, as the commonly used agents are not well-suited for inflamed areas. Recent studies gastrointestinal tract (GIT) in UC. Further systemic research is needed to explore novel contrast agents that can specifically image disease processes in this disease setting.
Publisher
Cold Spring Harbor Laboratory
Reference39 articles.
1. Arora, Z. & Shen, B . Biological therapy for ulcerative colitis. Gastroenterology Report (2015).
2. Lee, M. & Chang, E. B . Inflammatory Bowel Diseases (IBD) and the Microbiome—Searching the Crime Scene for Clues. Gastroenterology (2021).
3. Seyedian, S. S. , Nokhostin, F. & Malamir, M. D . A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. Journal of medicine and life (2019).
4. Levine, J. S. & Burakoff, R . Extraintestinal manifestations of inflammatory bowel disease. Gastroenterology and Hepatology (2011).
5. Tontini, G. E. , Vecchi, M. , Pastorelli, L. , Neurath, M. F. & Neumann, H . Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World J. Gastroenterol. (2015).